Clinical Trial
Published on 24 Jul 2024
The optimal dose of dexmedetomidine as a 0.59% ropivacaine adjuvant for epidural anesthesia in great saphenous varicose vein surgery, based on hemodynamics and anesthesia efficacy: a randomized, controlled, double-blind clinical trial
in Intensive Care Medicine and Anesthesiology
![The optimal dose of dexmedetomidine as a 0.59% ropivacaine adjuvant for epidural anesthesia in great saphenous varicose vein surgery, based on hemodynamics and anesthesia efficacy: a randomized, controlled, double-blind clinical trial](https://www.frontiersin.org/files/myhome article library/1426512/1426512_Thumb_400.jpg)